[Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
D000368:Aged; D001688:Biological Products / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D009361:Neoplasm Invasiveness; D010844:Picibanil / Q000008:administration & dosage* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D013601:T-Lymphocytes
D001688:Biological Products; D010844:Picibanil